These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7843812

  • 1. Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin.
    Onyeji CO, Nightingale CH, Marangos MN.
    Infection; 1994; 22(5):338-42. PubMed ID: 7843812
    [Abstract] [Full Text] [Related]

  • 2. Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA).
    Pumerantz A, Muppidi K, Agnihotri S, Guerra C, Venketaraman V, Wang J, Betageri G.
    Int J Antimicrob Agents; 2011 Feb; 37(2):140-4. PubMed ID: 21130608
    [Abstract] [Full Text] [Related]

  • 3. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000 Feb; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

  • 4. Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils.
    Pedrera MI, Barriga C, Rodriguez AB.
    Comp Immunol Microbiol Infect Dis; 1995 Feb; 18(2):123-8. PubMed ID: 7621668
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L, De Vecchi E, Nicola L, Gismondo MR.
    BMC Infect Dis; 2007 Sep 21; 7():111. PubMed ID: 17888153
    [Abstract] [Full Text] [Related]

  • 9. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance].
    Serazin V, Mougeot C, Libert JM.
    Pathol Biol (Paris); 1994 Apr 21; 42(4):323-7. PubMed ID: 7808785
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z, Ofer O, Shmuely H.
    Isr Med Assoc J; 2005 Mar 21; 7(3):148-50. PubMed ID: 15792257
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E, Falcone M, Baiocchi P, Pompeo ME, Pierciaccante A, Penni A, Venditti M.
    Infez Med; 2005 Jun 21; 13(2):97-102. PubMed ID: 16220029
    [Abstract] [Full Text] [Related]

  • 12. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, Ulusoy S.
    Int J Antimicrob Agents; 2005 Nov 21; 26(5):412-5. PubMed ID: 16221540
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters.
    Kropec A, Huebner J, Wursthorn M, Daschner FD.
    Eur J Clin Microbiol Infect Dis; 1993 Jul 21; 12(7):545-8. PubMed ID: 8404917
    [Abstract] [Full Text] [Related]

  • 14. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
    Kouda M, Homma S, Udagawa I, Tamura K, Fukuhara J, Takeuchi M.
    Jpn J Antibiot; 1999 Dec 21; 52(12):681-9. PubMed ID: 10695023
    [Abstract] [Full Text] [Related]

  • 15. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA, Jin YF, Ashby JP, Andrews JM, Wise R.
    J Antimicrob Chemother; 1990 Aug 21; 26(2):203-7. PubMed ID: 2145256
    [Abstract] [Full Text] [Related]

  • 16. The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus.
    van der Broek PJ, Buys LF.
    J Antimicrob Chemother; 1990 May 21; 25(5):787-95. PubMed ID: 2142684
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL, Kiffer CR, Mendes CM, Nicolau DP.
    Clin Microbiol Infect; 2008 Feb 21; 14(2):116-23. PubMed ID: 18076672
    [Abstract] [Full Text] [Related]

  • 18. Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
    Kobayashi Y.
    J Infect Chemother; 2005 Oct 21; 11(5):259-61. PubMed ID: 16258825
    [Abstract] [Full Text] [Related]

  • 19. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.
    Vaudaux P, Francois P, Berger-Bächi B, Lew DP.
    J Antimicrob Chemother; 2001 Feb 21; 47(2):163-70. PubMed ID: 11157900
    [Abstract] [Full Text] [Related]

  • 20. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
    Bowker KE, Noel AR, MacGowan AP.
    J Antimicrob Chemother; 2009 Nov 21; 64(5):1044-51. PubMed ID: 19759041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.